In the first quarter of 2021, CCADD got off to a good start with a new project deal with Korea Ginseng Corporation (KGC).

Korea’s leading ginseng brand for over a century, KGC has a distinguished track record of making quality dietary products. CCADD, on the other side of the deal, has been receiving high marks on its clinical science expertise. So, the handshake between the two definitely holds the promise of achieving something big and previously unimagined.

And the promise is becoming real. Staring this March, KGC and CCADD set out on a project to develop a mobile healthcare application called ‘Care Now Q.’ Once complete, the mobile application will be the first in the market that utilizes data from medical checkups, direct-to-consumer genetic tests, and health survey results to recommend individualized health guidance and dietary supplement suggestions. For this ambitious project, CCADD will play an active role as a clinical expert and project manager, providing expertise and orchestrating the entire process. This project will be led by Yoomin Jeon (team leader), Jung-Hyun Won, and David Seung U Lee under the supervision of Prof. Howard Lee.

The stakes are high. This project will not only turn the idea of individualized health management into reality but also open the door for CCADD to a new area of research, moving forward.